搜索临床试验以:IMMU-114
总计1779个结果
-
Elisabethinen HospitalBaxter Healthcare Corporation; ASOKLIF未知
-
Gilead Sciences主动,不招人
-
Azienda Ospedaliero-Universitaria di Parma终止
-
National Institute of Allergy and Infectious Diseases...National Institutes of Health (NIH)终止
-
Western Health and Social Care TrustUniversity of Ulster招聘中
-
Changchun Intellicrown Pharmaceutical Co. LTD招聘中
-
Gilead SciencesParexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions (Beijing) Co., Ltd主动,不招人
-
Promontory Therapeutics Inc.主动,不招人泌尿生殖系统肿瘤 | 按部位分类的肿瘤 | 生殖器肿瘤,男性 | 前列腺肿瘤 | 晚期实体瘤 | mCRPC | 转移性去势抵抗性前列腺癌 | CRPC | PT-112美国, 法国
-
Hoffmann-La Roche完全的
-
Gilead Sciences招聘中
-
Wendell Yap, MDUniversity of Kansas Medical Center不再可用
-
Yale UniversityNational Center for Complementary and Integrative Health (NCCIH)招聘中
-
Qlaris Bio, Inc.招聘中
-
Gilead Sciences撤销
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Gilead Sciences主动,不招人
-
Impatients N.V. trading as myTomorrowsImmodulon Therapeutics Ltd不再可用
-
University of Alabama at Birmingham招聘中
-
AbbVieAbbVie招聘中
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS)招聘中
-
JCR Pharmaceuticals Co., Ltd.招聘中
-
Millennium Pharmaceuticals, Inc.终止
-
Minerva Neurosciences完全的
-
Immunome, Inc.United States Department of Defense招聘中